Thyrocare has taken aboard SigTuple's AI-powered technology (SigTuple's AI100) to automate the manual microscopy process across its network. This is expected to significantly reduce the turnaround time, standardise reporting quality and increase efficiency multi-fold, the company said in a statement on Wednesday.

Rahul Guha, Managing Director, Thyrocare Technologies, said, “Digitalising microscopy has the potential to transform the face of diagnostics throughout India, and AI-integration in diagnostics is a game-changer. It has brought remarkable precision to our diagnostic capabilities. With the flagship product SigTuple AI100, we can now provide more accurate results, increased productivity, reduced TAT, and all this at lower costs.”

Thyrocare is in the process of expanding its presence across tier-2/3 cities and towns. Digital microscopy with artificial intelligence will be an enabler in a big way to do peer review on abnormal samples reporting and diagnosing several critical disorders like malarial infections, cancers, etc., the company said in the statement.  

SigTuple AI100 is the solution for AI-assisted digital pathology. Dr Tathagato Rai Dastidar, Founder and CEO, SigTuple commented on the association, “ AI100 was built to solve the problem of digital pathology with that aim in mind. We are very excited to see that vision coming true in real life, and that our product is now being deployed by most of the key laboratory networks in the country."